First-in-Human (FIH) Study of the Fully-Human Kappa-Lambda CD19/CD47 Bispecific Antibody TG-1801 in Patients (pts) with B-Cell Lymphoma
- Resource Type
- Abstract
- Source
- In
Blood 15 November 2022 140 Supplement 1:6599-6601 - Subject
- Language
- ISSN
- 0006-4971